by John Conrad | Jun 17, 2024 | NewsBrief
John Flavin, CEO of Portal Innovations, recently appeared on CNBC’s Fast Money to discuss GLP-1 drugs, early-stage biotech investing, and Portal’s unique investment model. On the topic of GLP-1 drugs for obesity and diabetes, Flavin noted that while there...